Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This compound is a small molecule with the molecular formula C18H22N6O3 and a molecular weight of approximately 370.41 g/mol[1][3][6]. It belongs to the class of benzamides and contains an aminopyrimidine core substituted with a cyclohexylmethoxy group and a nitroso group at position 5. The compound has been referenced in chemical databases and structural biology resources but does not have any reported clinical indications or approved uses as of current data. Its mechanism of action is not fully elucidated in available literature, but it is classified as an experimental small molecule drug candidate[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 4-{[4-amino-6-(cyclohexylmethoxy)-5-nitrosopyrimidin-2-yl]amino}benzamide.